Get the Stockscreener App
0.00
100.00%
-1.725
Eiger BioPharmaceuticals Inc Stock (EIGR) Forecast
The Eiger BioPharmaceuticals Inc (EIGR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.2904, representing a + increase from the current price of $0.00. The highest analyst price target is $5.0643, and the lowest is $1.5166.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EIGR Price Target
Average 4.2278
(+ Upside)
Is Eiger BioPharmaceuticals Inc (EIGR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.31 | Buy |
| STOCH(9,6) | 17.40 | Buy |
| STOCHRSI(14) | 2.5045 | Buy |
| MACD(12,26) | -1.2283 | Sell |
| ADX(14) | 26.61 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -124.81 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.964
Sell
|
2.1231
Sell
|
| MA20 |
3.6528
Sell
|
3.2116
Sell
|
| MA50 |
5.1665
Sell
|
4.1984
Sell
|
| MA100 |
3.7511
Sell
|
3.7951
Sell
|
| MA200 |
2.1486
Sell
|
2.9184
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EIGR could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on EIGR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.31 indicates that EIGR is oversold. This indicates that EIGR price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.4 indicates that EIGR is oversold. This indicates that EIGR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.5045 indicates that EIGR is oversold. This suggests that EIGR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.61 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -124.81 indicates that EIGR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term EIGR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eiger BioPharmaceuticals Inc financial reports and earnings history, Eiger BioPharmaceuticals Inc (EIGR) stock could reach $7.0968 by 2030, $3.8587 by 2040 and $15.41 by 2050. See the projected annual prices until 2050 of the Eiger BioPharmaceuticals Inc stock below:
- Eiger BioPharmaceuticals Inc (EIGR) is expected to reach an average price of $0.9151 in 2035, with a high prediction of $1.0151 and a low estimate of $0.9301. This indicates an $ rise from the last recorded price of $0.00.
- Eiger BioPharmaceuticals Inc (EIGR) stock is projected to chart a bullish course in 2040, with an average price target of $4.0087, representing an $ surge from its current level. The forecast ranges from a conservative $3.6379 to a sky-high $3.8587.
- Our analysts predict Eiger BioPharmaceuticals Inc (EIGR) to jump by 2045, soaring from $2.4524 to an average price of $2.8429, potentially reaching $2.5829. While $2.4524 is the low estimate, the potential upside is significant.
- Eiger BioPharmaceuticals Inc (EIGR) stock is expected to climb by 2050, reaching an average of $14.89, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.41 and $15.39, respectively, highlighting the market's uncertainty.
Eiger BioPharmaceuticals Inc Stock (EIGR) Year by Year Forecast
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2024
Our forecast for EIGR stock price in 2024 now indicates an average price target of $3.0911 with a high forecast of $6.0994 and a low forecast of $0.0829. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $1.7416 | $1.5166 | $5.0643 | + |
| June, 2024 | $2.0013 | $1.414 | $2.7089 | + |
| July, 2024 | $1.3085 | $0.5038 | $2.5187 | + |
| August, 2024 | $2.5133 | $1.326 | $3.166 | + |
| September, 2024 | $2.3605 | $0.9681 | $2.6357 | + |
| October, 2024 | $2.0952 | $1.8879 | $4.053 | + |
| November, 2024 | $2.7908 | $1.221 | $3.1149 | + |
| December, 2024 | $3.3271 | $1.6474 | $4.4547 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2025
Eiger BioPharmaceuticals Inc Stock (EIGR) is expected to reach an average price of $4.0544 in 2025, with a high prediction of $7.9518 and a low estimate of $0.1571. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.0369 | $2.9096 | $5.7844 | + |
| February, 2025 | $6.6666 | $4.7793 | $7.9518 | + |
| March, 2025 | $4.3688 | $4.2088 | $7.3815 | + |
| April, 2025 | $0.8586 | $0.6886 | $4.7312 | + |
| May, 2025 | $0.4717 | $0.8417 | $0.791 | + |
| June, 2025 | $0.2205 | $0.2105 | $1.3756 | + |
| July, 2025 | $6.0802 | $0.1571 | $6.5702 | + |
| August, 2025 | $4.00 | $2.3575 | $6.9327 | + |
| September, 2025 | $2.5622 | $2.1397 | $4.4124 | + |
| October, 2025 | $4.6219 | $2.727 | $5.9969 | + |
| November, 2025 | $3.4616 | $2.8666 | $5.9643 | + |
| December, 2025 | $1.6038 | $1.1938 | $4.6341 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2026
The predicted value for Eiger BioPharmaceuticals Inc (EIGR) in 2026 is set at an average of $4.7094. Estimates vary from a peak of $7.7626 to a trough of $1.6563, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6336 | $1.6563 | $4.3411 | + |
| February, 2026 | $3.0833 | $2.396 | $4.9809 | + |
| March, 2026 | $4.3555 | $2.5482 | $4.4606 | + |
| April, 2026 | $4.9052 | $3.9079 | $6.8604 | + |
| May, 2026 | $5.935 | $3.6577 | $7.7626 | + |
| June, 2026 | $3.3572 | $2.6572 | $6.0074 | + |
| July, 2026 | $2.8869 | $2.5501 | $3.8245 | + |
| August, 2026 | $2.7991 | $2.4794 | $3.9742 | + |
| September, 2026 | $3.1188 | $2.464 | $3.1888 | + |
| October, 2026 | $3.8286 | $2.6113 | $4.5237 | + |
| November, 2026 | $3.9308 | $2.7283 | $4.3507 | + |
| December, 2026 | $3.3405 | $2.5432 | $3.9132 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eiger BioPharmaceuticals Inc (EIGR) is $3.2041, with a high forecast of $6.4022 and a low forecast of $0.00588. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.1203 | $2.0903 | $3.443 | + |
| February, 2027 | $2.06 | $1.7078 | $2.5276 | + |
| March, 2027 | $2.2522 | $1.4225 | $3.8673 | + |
| April, 2027 | $1.5019 | $0.9319 | $2.4346 | + |
| May, 2027 | $0.1141 | $0.00588 | $1.5144 | + |
| June, 2027 | $0.6439 | $0.0184 | $0.9039 | + |
| July, 2027 | $0.4636 | $0.1587 | $0.7863 | + |
| August, 2027 | $5.0858 | $0.3361 | $6.4022 | + |
| September, 2027 | $3.4455 | $2.5131 | $5.5582 | + |
| October, 2027 | $3.4453 | $2.453 | $5.0904 | + |
| November, 2027 | $3.1075 | $1.725 | $3.8202 | + |
| December, 2027 | $5.3572 | $2.7599 | $6.1172 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2028
In 2028, Eiger BioPharmaceuticals Inc (EIGR) is projected to reach an average price of $3.541, with a high projection of $7.0494 and a low estimate of $0.0326. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.1294 | $5.0397 | $7.0494 | + |
| February, 2028 | $3.9991 | $3.1291 | $6.2718 | + |
| March, 2028 | $3.7389 | $3.6189 | $5.7365 | + |
| April, 2028 | $2.6586 | $2.3576 | $3.8213 | + |
| May, 2028 | $2.2508 | $1.5735 | $3.0611 | + |
| June, 2028 | $1.0194 | $1.0819 | $2.3633 | + |
| July, 2028 | $0.5773 | $0.6573 | $0.827 | + |
| August, 2028 | $0.3525 | $0.1201 | $1.0801 | + |
| September, 2028 | $0.5378 | $0.0326 | $0.3599 | + |
| October, 2028 | $0.4856 | $0.6953 | $0.6674 | + |
| November, 2028 | $0.3758 | $0.4158 | $0.4407 | + |
| December, 2028 | $0.2161 | $0.2561 | $0.1685 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2029
The 2029 price forecast for Eiger BioPharmaceuticals Inc Stock (EIGR) is $4.6296 on average, with a high prediction of $9.2491 and a low estimate of $0.0102. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4307 | $0.3537 | $0.304 | + |
| February, 2029 | $0.3442 | $0.3442 | $0.3251 | + |
| March, 2029 | $0.0588 | $0.1844 | $0.2517 | + |
| April, 2029 | $0.3722 | $0.043 | $0.3172 | + |
| May, 2029 | $0.2777 | $0.3516 | $0.3478 | + |
| June, 2029 | $0.1758 | $0.2027 | $0.2676 | + |
| July, 2029 | $0.00486 | $0.0102 | $0.07 | + |
| August, 2029 | $9.3391 | $0.0357 | $9.2491 | + |
| September, 2029 | $4.9396 | $6.4196 | $8.2533 | + |
| October, 2029 | $5.7353 | $5.2399 | $5.1553 | + |
| November, 2029 | $5.4358 | $5.5655 | $5.1304 | + |
| December, 2029 | $7.1214 | $4.3263 | $4.406 | + |
Eiger BioPharmaceuticals Inc Stock (EIGR) Price Forecast for 2030
Eiger BioPharmaceuticals Inc Stock (EIGR) is expected to reach an average price of $3.9496 in 2030, with a high forecast of $7.1276 and a low forecast of $0.7716. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.1019 | $7.3917 | $7.0968 | + |
| February, 2030 | $7.6424 | $7.0473 | $6.8024 | + |
| March, 2030 | $7.4679 | $7.1178 | $7.1276 | + |
| April, 2030 | $6.5786 | $6.2534 | $6.1383 | + |
| May, 2030 | $6.1241 | $7.2091 | $6.8588 | + |
| June, 2030 | $6.2596 | $5.4845 | $5.3342 | + |
| July, 2030 | $6.2452 | $6.5452 | $6.2798 | + |
| August, 2030 | $4.7357 | $5.3455 | $5.2904 | + |
| September, 2030 | $3.0214 | $3.1011 | $3.7809 | + |
| October, 2030 | $1.6119 | $0.7716 | $1.0919 | + |
| November, 2030 | $3.2724 | $1.937 | $2.4474 | + |
| December, 2030 | $9.043 | $3.7075 | $6.688 | + |
1.53%
3.38%
Cap:
|
Volume (24h):